Share on StockTwits

Express Scripts Holding Company (NASDAQ:ESRX) Director Seymour Sternberg unloaded 15,508 shares of the company’s stock on the open market in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of $74.12, for a total transaction of $1,149,452.96. Following the completion of the sale, the director now directly owns 4,769 shares in the company, valued at approximately $353,478. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Express Scripts Holding Company (NASDAQ:ESRX) traded down 0.65% on Tuesday, hitting $73.45. The stock had a trading volume of 3,161,332 shares. Express Scripts Holding Company has a one year low of $59.20 and a one year high of $79.37. The stock’s 50-day moving average is $70.71 and its 200-day moving average is $71.63. The company has a market cap of $54.753 billion and a price-to-earnings ratio of 33.03.

Express Scripts Holding Company (NASDAQ:ESRX) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.01. The company had revenue of $25.11 billion for the quarter, compared to the consensus estimate of $24.42 billion. During the same quarter in the previous year, the company posted $1.12 earnings per share. The company’s revenue for the quarter was down 4.8% on a year-over-year basis. Analysts expect that Express Scripts Holding Company will post $4.88 EPS for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Cowen and Company cut their price target on shares of Express Scripts Holding Company from $77.00 to $76.00 in a research note on Thursday, July 31st. They now have a “market perform” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Express Scripts Holding Company in a research note on Wednesday, July 30th. They now have a $71.00 price target on the stock. Finally, analysts at Jefferies Group cut their price target on shares of Express Scripts Holding Company from $86.00 to $80.00 in a research note on Wednesday, July 30th. They now have a “buy” rating on the stock. Four analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $79.78.

Express Scripts, Inc is a pharmacy benefit management (NASDAQ:ESRX) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.